Lataa...
Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
Checkpoint blockade therapy, for example using antibodies against CTLA-4 and PD-1/PD-L1, relieves T cells from the suppression by inhibitory checkpoints in the tumor microenvironment; thereby achieving good outcomes in the treatment of different cancer types. Like T cells, natural killer (NK) cell i...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7344328/ https://ncbi.nlm.nih.gov/pubmed/32714324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01295 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|